Wanbury slips on receiving 5 observations from USFDA for Tanuku Plant

06 Mar 2018 Evaluate

Wanbury is currently trading at Rs. 38.00, down by 0.45 points or 1.17% from its previous closing of Rs. 38.45 on the BSE.

The scrip opened at Rs. 38.00 and has touched a high and low of Rs. 40.15 and Rs. 38.00 respectively.

The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 62.90 on 03-May-2017 and a 52 week low of Rs. 32.85 on 14-Nov-2017.

Last one week high and low of the scrip stood at Rs. 41.00 and Rs. 37.95 respectively. The current market cap of the company is Rs. 88.24 crore.

The promoters holding in the company stood at 56.11%, while Institutions and Non-Institutions held 2.43% and 41.46% respectively.

Wanbury has completed the United States Food and Drug Administration (USFDA) inspection at its major API facility in Tanuku Plant, Andhra Pradesh with five observations. The same is being addressed and will be resolved by the Regulatory Team.  The audit was carried out for a period of 5 days and concluded on March 2, 2018.

Wanbury is a pharmaceutical company and offers active pharmaceutical ingredient (API) in over 70 countries.


Wanbury Share Price

49.40 -1.10 (-2.18%)
09-Dec-2022 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 992.75
Cipla 1107.45
Dr. Reddys Lab 4408.00
Lupin 750.90
Zydus Lifesciences 407.40
View more..